Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
about
Ebola virus diseaseEbola virus disease and critical illness.Current Landscape of Antiviral Drug DiscoveryEbola Hemorrhagic Fever as a Public Health Emergency of International Concern; a Review ArticleRole of Marine Natural Products in the Genesis of Antiviral AgentsAddressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksEbola: a holistic approach is required to achieve effective management and controlPre-symptomatic diagnosis and treatment of filovirus diseasesApproved Antiviral Drugs over the Past 50 YearsClomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic ImplicationsMolecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine TriphosphateExperimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaA Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola VirusOffering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infectionsEbola Viral Disease in West Africa: A Threat to Global Health, Economy and Political StabilityA response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic responsePublic health challenges and legacies of Japan's response to the Ebola virus disease outbreak in West Africa 2014 to 2015.Ebola virus disease: What clinicians in the United States need to know.Japanese Surveillance Systems and Treatment for Influenza.Ebola virus - from neglected threat to global emergency state.Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Potential clinical treatment for Ebola pandemic.Favipiravir: a new medication for the Ebola virus disease pandemic.Ebola: Implications and Perspectives.Influenza antivirals currently in late-phase clinical trial.Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome VirusHemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex.Treatment of ebola virus disease.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Small molecules with antiviral activity against the Ebola virusEbola hemorrhagic fever: current outbreak and progress in finding a cure.Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs.Federal funding in support of Ebola medical countermeasures R&DBacks against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreakAntiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.
P2860
Q24563097-B1341EF4-8B5E-4B60-87DE-243FF4D47E8AQ26250274-DEF3A3B3-D28C-4D64-9429-3D42131AF516Q26766639-711FE0C4-9B02-4F0F-A177-615809168405Q26778083-EF2C95C4-17BC-4530-A7C1-433D261543DFQ26796360-9A2EDBBB-5B09-439D-B31B-97A6B0639A6EQ26801423-35CFE46E-D133-463C-9BD5-F071782CE7A4Q26823792-3DE9024D-E658-4073-9BCB-F9C3CAFC00B3Q26823831-2AB18AF1-C5DD-44E2-9401-48088F615501Q27755387-66551F18-2D73-431A-BF02-A66AB3D77E4EQ28387522-5482F17B-7402-41B2-B983-86CD72ACF184Q28548547-8E2EF41E-AC73-484E-B50D-AD899D5E0BF2Q28550455-136062D0-36F1-4770-99E4-0ED42B185137Q28552295-7E446A65-E546-4179-89EE-3A333A1BDE67Q29994672-5C3EC822-BE1A-4C61-B0D3-3CC5E37499F3Q30148821-578B4060-C612-409D-942A-289549113BFEQ30196960-9BCD1A35-C608-471F-A0C9-6065632AD56AQ30202111-6021B8C7-3389-4863-ABD9-8D9CCFF5FE28Q30203249-153A7EBE-C591-4514-9C88-4087951AE458Q30239895-07DB5A72-55FA-4EF8-927F-E604C408B5B2Q30245153-6C216C57-6603-4E67-A08B-DB41BEEA47CCQ30251949-C5965378-18D5-4B6B-A239-B77EF4758FCEQ30252022-A3EB7306-6563-4E3A-BB44-1C1831146085Q30366997-338CB03F-9B59-47EB-AC2A-4B2499C987F7Q30370190-E30675AE-78D8-4D71-99F3-4C337A45C87CQ30378672-4AC6A409-C218-4115-95FA-BAA375E00B01Q30398099-522BAEC6-F208-4F65-8EE8-550D9923002AQ33433096-55E360DD-3EC6-45B2-A887-3504ED010E5CQ33439713-4D009468-1E42-4726-BB0B-5FD368B9279EQ33825147-CF7B9B15-23D1-4923-8BA2-B6AAE09D762CQ34269400-77DF3997-2914-423E-BF73-D2F4B15734ADQ34460182-B9F5E981-AD5F-4C1D-A09C-E51DB78E5AA3Q34463780-9E094B71-7B04-4108-8182-BD5B81DC4042Q34464403-910467E4-ADDF-4D6F-B2E2-C2ECAD16EE7AQ34491250-5432F493-E49F-47B0-B5C3-5DE2E40A6026Q34516555-11176DC3-9660-47D2-A789-60316E2CFC25Q34539396-56AB458F-B792-43D1-A5D0-A8EE5B992D42Q35050840-E61C20C4-D2D0-4398-AC36-5D43171D83ABQ35317518-237C6226-5FB0-413E-9FC2-C40A57B7D682Q35598919-A41436F3-6F0D-40AB-A4B0-620478531124Q35605579-881EF9F4-C113-4A8A-AA24-8D7C748E6DD6
P2860
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Successful treatment of advanc ...... avir) in a small animal model.
@ast
Successful treatment of advanc ...... avir) in a small animal model.
@en
Successful treatment of advanced Ebola virus infection with T-705
@nl
type
label
Successful treatment of advanc ...... avir) in a small animal model.
@ast
Successful treatment of advanc ...... avir) in a small animal model.
@en
Successful treatment of advanced Ebola virus infection with T-705
@nl
prefLabel
Successful treatment of advanc ...... avir) in a small animal model.
@ast
Successful treatment of advanc ...... avir) in a small animal model.
@en
Successful treatment of advanced Ebola virus infection with T-705
@nl
P2093
P1433
P1476
Successful treatment of advanc ...... avir) in a small animal model.
@en
P2093
Anja Lüdtke
Lisa Oestereich
Stephanie Wurr
Toni Rieger
P356
10.1016/J.ANTIVIRAL.2014.02.014
P577
2014-02-26T00:00:00Z